Cochrane Abstracts
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes: Cochrane systematic review
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Platelet Glycoprotein IIb/IIIa Blockers During Percutaneous Coronary Intervention and as the Initial Medical Treatment of non-ST Segment Elevation Acute Coronary Syndromes: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439019/all/MVA85A_vaccine_to_enhance_BCG_for_preventing_tuberculosis_Unchanged. Accessed 28 March 2023.
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439019/all/MVA85A_vaccine_to_enhance_BCG_for_preventing_tuberculosis_Unchanged. Accessed March 28, 2023.
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439019/all/MVA85A_vaccine_to_enhance_BCG_for_preventing_tuberculosis_Unchanged
Platelet Glycoprotein IIb/IIIa Blockers During Percutaneous Coronary Intervention and as the Initial Medical Treatment of non-ST Segment Elevation Acute Coronary Syndromes: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439019/all/MVA85A_vaccine_to_enhance_BCG_for_preventing_tuberculosis_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes: Cochrane systematic review
ID - 439019
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439019/all/MVA85A_vaccine_to_enhance_BCG_for_preventing_tuberculosis_Unchanged
DB - Evidence Central
DP - Unbound Medicine
ER -
